Patent Application Titled "Immunogenic Compositions Comprising Mycobacterium Tuberculosis Polypeptides And Fusions Thereof" Published Online (USPTO 20240140997).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      A patent application titled "Immunogenic Compositions Comprising Mycobacterium Tuberculosis Polypeptides And Fusions Thereof" has been published by the US Patent and Trademark Office. The invention focuses on compositions containing combinations of Mycobacterium tuberculosis antigens and their use in diagnosing, treating, and preventing tuberculosis. The invention offers improved immunogenicity and is particularly valuable in vaccine development. The patent application provides specific combinations of antigens that can be used in the compositions, including a long list of specific antigens. [Extracted from the article]
    • Abstract:
      Copyright of Vaccine Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)